US Patent:
20040167183, Aug 26, 2004
Inventors:
Sean Klopfenstein - Loveland OH, US
Matthew Maier - Cincinnati OH, US
David Jones - Milford OH, US
Jeffrey Gray - Loveland OH, US
Matthew Pokross - Loveland OH, US
Kevin Peters - Loveland OH, US
Artem Evdokimov - Loveland OH, US
Assignee:
The Procter & Gamble Company
International Classification:
C07D213/36
A61K031/185
A61K031/44
US Classification:
514/357000, 514/553000, 514/408000, 562/037000, 546/329000
Abstract:
Compounds of formula (I): are effective in the treatment of protein tyrosine phosphatase (PTPase) mediated disorders such as diabetes.